CoChat

The Barrier of Hypoglycemia in Diabetes

Open access
Cryer, Philip E. · 2008 · Diabetes

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Glycemic control, a worthwhile goal for people with diabetes, is limited by the barrier of iatrogenic hypoglycemia (1). Iatrogenic hypoglycemia 1 ) causes recurrent morbidity in most people with type 1 diabetes and many with advanced type 2 diabetes and is sometimes fatal, 2 ) compromises physiological and behavioral defenses against subsequent falling plasma glucose concentrations and thus causes a vicious cycle of recurrent hypoglycemia, and 3 ) precludes maintenance of euglycemia over a lifetime of diabetes and therefore full realization of the vascular benefits of glycemic control. The premise of this “Perspective in Diabetes” is that insight into the pathophysiology of glucose counterregulation in diabetes leads to understanding of the frequency and impact of, risk factors for, and prevention of iatrogenic hypoglycemia. Partial glycemic control reduces, but does not eliminate, the development of microvascular complications of diabetes (retinopathy, nephropathy, and neuropathy) in type 1 (2) and type 2 (3,4) diabetes. Extrapolation of the Diabetes Control and Complications Trial (DCCT) retinopathy data suggests that long-term maintenance of euglycemia might eliminate those complications (5). Follow-up of the DCCT patients seemingly indicates that a period of earlier partial glycemic control reduces the development of macrovascular complications in type 1 diabetes (6). Aside from the metformin subset of the U.K. Prospective Diabetes Study (4), randomized controlled trials of intensive glycemic therapy have not documented a cardiovascular mortality benefit in type 2 diabetes (3,7,8). However, those trials do not exclude a cardiovascular benefit if glycemic control, or even partial glycemic control, could be maintained over a longer period of time. In any event, given its documented microvascular benefit, maintenance of euglycemia over a lifetime of diabetes would be in the best interest of people with diabetes if that could be accomplished safely. Unfortunately, maintenance of euglycemia over a lifetime of diabetes …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db08-1084

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Physiological and behavioral defenses against hypoglycemia in humans. ACh, acetylcholine; NE, norepinephrine; PNS, parasympathetic nervous system; SNS, sympathetic nervous system. From Cryer PE: Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J Clin Invest 116:14701–473, 2006. © 2006, American Society for Clinical Investigation. All rights reserved.
FIG. 1. Physiological and behavioral defenses against hypoglycemia in humans. ACh, acetylcholine; NE, norepinephrine; PNS, parasympathetic nervous system; SNS, sympathetic nervous system. From Cryer PE: Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J Clin Invest 116:14701–473, 2006. © 2006, American Society for Clinical Investigation. All rights reserved.CC BY-NC-ND · PubMed Central
FIG. 2. Schematic diagram of HAAF in diabetes. Modified from Cryer PE: Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:22722–279, 2004. © 2004 Massachusetts Medical Society. All rights reserved.
FIG. 2. Schematic diagram of HAAF in diabetes. Modified from Cryer PE: Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:22722–279, 2004. © 2004 Massachusetts Medical Society. All rights reserved.CC BY-NC-ND · PubMed Central
FIG. 3. Pancreatic islet and hypothalamic and cerebral network mechanisms of HAAF in diabetes.
FIG. 3. Pancreatic islet and hypothalamic and cerebral network mechanisms of HAAF in diabetes.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Cryer PE: Hypoglycemia in Diabetes: Pathophysiology, Prevalence, and Prevention. American Diabetes Association, Alexandria, VA. In press

Cited by

See all 725

Metadata

Authors
Cryer, P. E.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Cryer, Philip E.
Venue
Diabetes
Published
2008-12-01
Volume
57
Issue
12
Pages
3169-3176
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2014554878
Cited by
725
References
51
Citations by year
2026: 15 · 2025: 23 · 2024: 35 · 2023: 31 · 2022: 33 · 2021: 47 · 2020: 34 · 2019: 48 · 2018: 38 · 2017: 38 · 2016: 53 · 2015: 66 · 2014: 49 · 2013: 56 · 2012: 43
FWCI
4.86
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (5p60dk020579-35, UL1TR000448, DK20579, P60-DK-20579, RR‐00036)
  • U.S. Public Health Service
  • National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027085, P60-DK20579, P60-DK-020579, T32DK007120)
  • National Center for Research Resources (MO1RR00036, UL1RR024992, M01RR000036)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
iatrogenic hypoglycemia, glycemic control, glucose counterregulation, type 1 diabetes, type 2 diabetes, normoglycemia, hypoglycemia prevention, hypoglycemia risk factors, microvascular complications, macrovascular complications
MeSH terms
Blood Glucose, Brain, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Coma, Female, Homeostasis, Humans, Hypoglycemia, Male, Risk Factors, Risk Reduction Behavior, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.